Literature DB >> 19625797

Is anesthesiology going soft?: trends in fragile pharmacology.

Talmage D Egan.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19625797     DOI： 10.1097/ALN.0b013e3181ae8460

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  7 in total

1.  AZD-3043: a novel, metabolically labile sedative-hypnotic agent with rapid and predictable emergence from hypnosis.

Authors:  Talmage D Egan; Shinju Obara; Thomas E Jenkins; Sarah S Jaw-Tsai; Shanti Amagasu; Daniel R Cook; Scott C Steffensen; David T Beattie
Journal:  Anesthesiology       Date:  2012-06       Impact factor: 7.892

2.  Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers.

Authors:  Xiao-Yan Sheng; Yan Liang; Xue-Yuan Yang; Li-E Li; Xia Ye; Xia Zhao; Yi-Min Cui
Journal:  Eur J Clin Pharmacol       Date:  2019-12-23       Impact factor: 2.953

Review 3.  Structural Modification in Anesthetic Drug Development for Prodrugs and Soft Drugs.

Authors:  Chaoyi Deng; Jin Liu; Wensheng Zhang
Journal:  Front Pharmacol       Date:  2022-07-01       Impact factor: 5.988

4.  Modifying methoxycarbonyl etomidate inter-ester spacer optimizes in vitro metabolic stability and in vivo hypnotic potency and duration of action.

Authors:  S Shaukat Husain; Ervin Pejo; Rile Ge; Douglas E Raines
Journal:  Anesthesiology       Date:  2012-11       Impact factor: 7.892

5.  Synthesis and evaluation of fluorine-substituted phenyl acetate derivatives as ultra-short recovery sedative/hypnotic agents.

Authors:  Heng Zhang; Xiangqing Xu; Yin Chen; Yinli Qiu; Xin Liu; Bi-Feng Liu; Guisen Zhang
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

Review 6.  Remimazolam: pharmacological characteristics and clinical applications in anesthesiology.

Authors:  Kyung Mi Kim
Journal:  Anesth Pain Med (Seoul)       Date:  2022-01-20

7.  Adrenocortical suppression and recovery after continuous hypnotic infusion: etomidate versus its soft analogue cyclopropyl-methoxycarbonyl metomidate.

Authors:  Rile Ge; Ervin Pejo; Joseph F Cotten; Douglas E Raines
Journal:  Crit Care       Date:  2013-01-30       Impact factor: 9.097
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.